Skip to main content
. 2023 Jul 21;6(7):e2324770. doi: 10.1001/jamanetworkopen.2023.24770

Table 2. Frequencies and AORs of Maternal and Perinatal Outcomes Between HCV-Positive and HCV-Negative Groups.

Variable HCV-negative (n = 69 901 008) HCV-positive (n = 137 259) AOR (95% CI)a
Maternal outcomes
Gestational anemia 6 525 131 (9.3) 18 046 (13.1) 0.99 (0.89-1.10)
Gestational diabetes 4 363 717 (6.2) 9049 (6.6) 1.04 (0.98-1.10)
Gestational hypertension 3 697 210 (5.3) 10 149 (7.4) 1.08 (1.03-1.14)
Preeclampsia/eclampsia 2 847 323 (4.1) 6781 (4.9) 1.00 (0.94-1.06)
Thyroid dysfunction complicating pregnancy 1 006 368 (1.4) 4564 (3.3) 1.07 (0.98-1.17)
Perinatal outcomes
Cesarean delivery 21 133 625 (30.2) 53 047 (38.6) 1.19 (1.15-1.22)
Stillbirth 479 088 (0.7) 1339 (1.0) 0.95 (0.87-1.03)
Spontaneous abortion 1 029 547 (1.5) 2263 (1.6) 0.88 (0.82-0.95)
Preterm labor 4 755 044 (6.8) 15 892 (11.6) 1.10 (1.05-1.14)
Poor fetal growth 1 423 590 (2.0) 7858 (5.7) 1.29 (1.21-1.37)
Fetal distress 10 891 929 (15.6) 27 853 (20.3) 1.11 (1.08-1.15)
Premature rupture of membranes 3 119 340 (4.5) 8618 (6.3) 1.04 (0.99-1.10)

Abbreviations: AOR, adjusted odds ratio; HCV, hepatitis C virus.

a

Adjusted for maternal age (by decade), race and ethnicity, substance use (by individual categories: tobacco, alcohol, opioids, cannabis, sedatives/hypnotics, cocaine, other stimulants, hallucinogens, inhalants, other psychoactives), HIV, hemodialysis, diabetes, thyroid disorders, hypertension, anemia, Charlson-Deyo Comorbidity Index, primary payer, median household income for mother’s zip code, hospital bed size, hospital location and teaching status, and geographic region.